Organization | Meir Medical Center

Meir Medical Center Report issue

Academic/Hospital Phase 2 Phase 4

Founded: Kfar Saba Israel (1956)

Organization Overview

First Clinical Trial

2011

NCT01167673

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Dr. Sidney Ben Chetrit | Meir Medical Center | Meir Medical hospital | NAFTALI TIMNA | Ophthalmology department, MeirMC, Israel

Active Ingredients

Drugs in Phase 4 Trials (1)

enoxaparin (lovenox) (2 trials)

Drugs in Phase 2 Trials (5)

bendamustine (treanda) (1 trial)

curcumin (1 trial)

obinutuzumab (gazyva) (1 trial)

selenomethionine se-75 (1 trial)

Drugs in Other Trials (10)

cefazolin (ancef) (1 trial)

cyclosporine (sandimmune) (1 trial)

estradiol (progynon depot) (1 trial)

fentanyl (Innovar) (1 trial)

letrozole (femara) (1 trial)

midazolam (versed) (1 trial)

omega-3 fatty acids (Omacor) (1 trial)

progesterone (progestasert) (1 trial)

recombinant human choriogonadotropin alfa (Ovidrel) (1 trial)

tranexamic acid (cyklokapron) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Irritable Bowel Syndrome (Phase 2)

Syndrome (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 10
# of Trial APIs: 16